Literature DB >> 34179594

Advances in activity-based diagnostics for infectious disease and microbiome health.

Leslie W Chan1,2.   

Abstract

In the human body, pathogens and the endogenous microbiome produce enzymes that aid in replication and survival. The activity from these enzymes as well as energy-dependent transport processes can be used as functional biomarkers for pathogen identification, antimicrobial treatment monitoring, and surveillance of microbiome health. To produce visual and/or quantifiable readouts from this activity, concepts from chemical biology and nanomedicine have been utilized to develop signal-producing probes for patient samples or for direct administration in vivo. In the context of infection, activity-based diagnostics offer several potential advantages over current diagnostics including the ability to differentiate between active infection and sterile inflammation, which is made possible by targeting microbial enzymes with orthogonal activity to that of the host. In this review, we discuss new developments in the making of activity-based infection diagnostics and the beginnings of microbiome activity-based diagnostics.

Entities:  

Keywords:  Activity-based diagnostics; chemical probes; enzyme nanosensors; infectious disease; microbiome

Year:  2021        PMID: 34179594      PMCID: PMC8224833          DOI: 10.1016/j.cobme.2021.100296

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN: 2468-4511


  50 in total

1.  Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy.

Authors:  Sazid Hussain; Jinmyoung Joo; Jinyoung Kang; Byungji Kim; Gary B Braun; Zhi-Gang She; Dokyoung Kim; Aman P Mann; Tarmo Mölder; Tambet Teesalu; Santina Carnazza; Salvatore Guglielmino; Michael J Sailor; Erkki Ruoslahti
Journal:  Nat Biomed Eng       Date:  2018-01-22       Impact factor: 25.671

2.  Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial.

Authors:  Muhammad Saeed Akhtar; Aitzaz Qaisar; Javaid Irfanullah; Javaid Iqbal; Bashar Khan; Mustansar Jehangir; Muhammad Afzal Nadeem; Muhammad Aleem Khan; Muhammad Shahzad Afzal; Ikram Ul-Haq; Muhammad Babar Imran
Journal:  J Nucl Med       Date:  2005-04       Impact factor: 10.057

3.  Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe.

Authors:  Yunfeng Cheng; Jinghang Xie; Kyung-Hyun Lee; Rajiv L Gaur; Aiguo Song; Tingting Dai; Hongjun Ren; Jiannan Wu; Zhaogang Sun; Niaz Banaei; Demir Akin; Jianghong Rao
Journal:  Sci Transl Med       Date:  2018-08-15       Impact factor: 17.956

4.  Comparison of noninvasive diagnostic tests for Helicobacter pylori infection.

Authors:  Nan-Jing Peng; Kwok-Hung Lai; Gin-Ho Lo; Ping-I Hsu
Journal:  Med Princ Pract       Date:  2008-12-04       Impact factor: 1.927

5.  Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe.

Authors:  Frank J Hernandez; Lingyan Huang; Michael E Olson; Kristy M Powers; Luiza I Hernandez; David K Meyerholz; Daniel R Thedens; Mark A Behlke; Alexander R Horswill; James O McNamara
Journal:  Nat Med       Date:  2014-02-02       Impact factor: 53.440

6.  Protease activity sensors noninvasively classify bacterial infections and antibiotic responses.

Authors:  Colin G Buss; Jaideep S Dudani; Reid T K Akana; Heather E Fleming; Sangeeta N Bhatia
Journal:  EBioMedicine       Date:  2018-11-29       Impact factor: 8.143

7.  Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract.

Authors:  Matthew H Foley; Sarah O'Flaherty; Rodolphe Barrangou; Casey M Theriot
Journal:  PLoS Pathog       Date:  2019-03-07       Impact factor: 6.823

8.  Imaging of tumor colonization by Escherichia coli using 18F-FDS PET.

Authors:  Sae-Ryung Kang; Eui Jeong Jo; Vu Hong Nguyen; Ying Zhang; Hee Seung Yoon; Ayoung Pyo; Dong-Yeon Kim; Yeongjin Hong; Hee-Seung Bom; Jung-Joon Min
Journal:  Theranostics       Date:  2020-04-01       Impact factor: 11.556

Review 9.  Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring.

Authors:  Ava P Soleimany; Sangeeta N Bhatia
Journal:  Trends Mol Med       Date:  2020-04-05       Impact factor: 11.951

10.  68Ga-labelled desferrioxamine-B for bacterial infection imaging.

Authors:  Milos Petrik; Eva Umlaufova; Vladislav Raclavsky; Andrea Palyzova; Vladimir Havlicek; Joachim Pfister; Christian Mair; Zbynek Novy; Miroslav Popper; Marian Hajduch; Clemens Decristoforo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-30       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.